Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025026
Filing Date
2024-10-11
Accepted
2024-10-11 16:15:07
Documents
1
Period of Report
2024-10-09

Document Format Files

Seq Description Document Type Size
1 form4-10112024_041004.html 4  
1 form4-10112024_041004.xml 4 4055
  Complete submission text file 0001415889-24-025026.txt   5552
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Hayes Christopher G. (Reporting) CIK: 0001805359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 241367721